Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study

Inclusion Criteria: * Patients with Stage I-IIA CTCL must be at least 18 years of age with a skin biopsy prior to enrolment confirming the diagnosis of mycosis fungoides. Exclusion Criteria: * Patients with Stage \>IIA CTCL at the time of enrolment * Women who are pregnant or planning to get pregnant, or unable/unwilling to use adequate contraception * Patients who were treated with topical retinoid therapy in the past 3 months * Patients who received any systemic CTCL therapy or systemic corticosteroid therapy within 30 days of the study start date * Patients who were treated with systemic isotretinoin or bexarotene within 3 months prior to the study start date, systemic acitretin within 2 years prior to study start date